Related Experiment Video
Updated: May 1, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
The global burden of cardiovascular diseases: a challenge to improve
Shanthi Mendis1, Oleg Chestnov
1Noncommunicable Diseases, World Health Organization, Geneva, Switzerland, mendiss@who.int.
Insights
Addressing the global cardiovascular disease epidemic requires multisectoral action and strengthened health systems. Prioritizing cost-effective interventions, guided by national action plans, is crucial for sustainable progress.
Area of Science:
- Public Health
- Epidemiology
- Health Policy
Background:
- Cardiovascular diseases (CVD) pose a significant global health challenge.
- Addressing this epidemic requires overcoming challenges in multisectoral action, health system capacity, and resource utilization.
Purpose of the Study:
- To outline strategies for combating the global cardiovascular disease epidemic.
- To emphasize the need for national action plans and prioritized interventions.
Main Methods:
- Review of challenges in CVD prevention and control.
- Analysis of resource requirements for cost-effective interventions.
- Guidance from the global action plan for noncommunicable diseases.
Main Results:
- Implementation of cost-effective CVD interventions requires a small percentage of health spending across income levels.
- Lower-income countries need approximately 4% of current health spending.
- Upper-middle and high-income countries require less than 1% of health spending.
Conclusions:
- Multisectoral national action plans and strengthened surveillance are essential for CVD control.
- Prioritizing cost-effective interventions and sustainable resource generation are key to implementation.
- Global targets for CVD prevention and control by 2025 necessitate immediate and strategic action.
Abstract:
There are many challenges that need to be overcome to address the global cardiovascular disease epidemic. They include (1) lack of multisectoral action to support reduction of behavioral risk factors and their determinants, (2) weak public health and health care system capacity for forging an accelerated national response, and (3) inefficient use of limited resources. To make progress, countries need to develop and implement multisectoral national action plans guided by the global action plan for prevention and control of noncommunicable diseases, strengthen surveillance and monitoring systems, and set national targets consistent with global voluntary targets, which are to be attained by 2025. In addition, a set of cost-effective preventive and curative interventions need to be prioritized. Further, resources need to be generated and capacity developed to ensure sustainable country-wide implementation of the prioritized interventions. According to WHO estimates, the implementation of a core set of very cost-effective interventions for prevention and control of cardiovascular disease requires about 4 % of current health spending in lower income countries, 2 % in lower middle income countries, and less than 1 % in upper middle income and high income countries.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure I: Introduction